ESCEO CONSENSUS ADVICE TO EMA REGARDING THE DRAFT GUIDELINES ON CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF RA

被引：0
|
作者：
Boers, M. [1 ,2 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Clin Epidemiol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Amsterdam Rheumatol & Immunol Ctr, Amsterdam, Netherlands
来源：
OSTEOPOROSIS INTERNATIONAL | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SE7
引用
收藏
页码：S79 / S79
页数：1
相关论文
共 13 条
  • [1] Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia
    Yamashita, Shizuya
    Masuda, Daisaku
    Akishita, Masahiro
    Arai, Hidenori
    Asada, Yujiro
    Dobashi, Kazushige
    Egashira, Kensuke
    Harada-Shiba, Mariko
    Hirata, Kenichi
    Ishibashi, Shun
    Kajinami, Kouji
    Kinoshita, Makoto
    Kozaki, Koichi
    Kuzuya, Masafumi
    Ogura, Masatsune
    Okamura, Tomonori
    Sato, Kayoko
    Shimano, Hitoshi
    Tsukamoto, Kazuhisa
    Yokode, Masayuki
    Yokote, Koutaro
    Yoshida, Masayuki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2020, 27 (11) : 1246 - 1254
  • [2] New guideline of the European Medicines Agency (EMA) on the clinical investigation of medicinal products in the treatment and prevention of diabetes mellitus
    van der Schueren, Bart
    Vrijlandt, Patrick
    Thomson, Andrew
    Janssen, Heidi
    Dunder, Kristina
    DIABETOLOGIA, 2024, 67 (07) : 1159 - 1162
  • [3] Clinical Investigation of Medicinal Products for the Treatment of Migraine
    Shaun Kilminster
    Andrew Dowson
    Donna Ellender
    International Journal of Pharmaceutical Medicine, 2003, 17 (3-4) : 113 - 115
  • [4] The clinical investigation of medicinal products in the treatment of schizophrenia
    不详
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1998, 8 (03) : 247 - 252
  • [5] WHAT IS THE INFLUENCE ON CLINICAL RESEARCH OF THE EMA GUIDELINE ON MEDICINAL PRODUCTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE?
    Caron, M.
    Acquadro, C.
    Emery, M. P.
    VALUE IN HEALTH, 2012, 15 (04) : A148 - A148
  • [6] REVISION OF EUROPEAN MEDICINE AGENCY'S (EMA) GUIDELINE ON CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS OTHER THAN NSAIDS FOR TREATMENT OF RHEUMATOID ARTHRITIS, 2016
    Rook, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 958 - 958
  • [7] Clinical investigation of medicinal products for treatment of amyotrophic lateral sclerosis (ALS)
    不详
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2001, 11 (02) : 187 - 189
  • [8] Clinical investigation of medicinal products in the treatment of Parkinson's disease (CPMP note for guidance)
    不详
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1999, 9 (05) : 443 - 449
  • [9] THE DEVELOPMENT OF A NEW EUROPEAN REGULATORY GUIDELINE ON THE CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF GOUT
    Rook, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 374 - 375
  • [10] EUROPEAN MEDICINES AGENCY'S GUIDELINE ON THE CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
    Da Silva, D.
    Rook, E.
    Semis-Costa, N.
    Mueller-Berghaus, J.
    Vesely, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 828 - 828
12